Low-dose interleukin-2 reverses chronic migraine-related sensitizations through peripheral interleukin-10 and transforming growth factor beta-1 signaling

Low-dose interleukin-2 (LD-IL-2) treatment has been shown to effectively reverse chronic migraine-related behaviors and the sensitization of trigeminal ganglion (TG) neurons through expansion and activation of peripheral regulatory T cells (Tregs) in mice. In this study, we investigated the molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zhaohua, Zhang, Jintao, Liu, Xuemei, Unsinger, Jacqueline, Hotchkiss, Richard S, Cao, Yu-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207571/
https://www.ncbi.nlm.nih.gov/pubmed/35733705
http://dx.doi.org/10.1016/j.ynpai.2022.100096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207571/
https://www.ncbi.nlm.nih.gov/pubmed/35733705
http://dx.doi.org/10.1016/j.ynpai.2022.100096

Ejemplares similares